Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-03-26 7:57 pm Sale | 13D | VERA THERAPEUTICS INC VERA | Sofinnova Venture Partners X L.P. | 2,813,837 5.4% | -834,459 (-22.87%) | View |
| 2024-02-20 7:11 pm Purchase | 13D | VERA THERAPEUTICS INC VERA | Sofinnova Venture Partners X L.P. | 3,648,296 6.9% | 171,215 (+4.92%) | View |
| 2024-02-14 4:57 pm Sale | 13G | VERA THERAPEUTICS INC VERA | CITADEL ADVISORS LLC | 43,447 0.1% | -1,948,106 (-97.82%) | View |
| 2024-02-14 4:10 pm Purchase | 13G | VERA THERAPEUTICS INC VERA | COMMODORE CAPITAL LP | 5,450,000 12.3% | 448,217 (+8.96%) | View |
| 2024-02-14 4:05 pm Purchase | 13G | VERA THERAPEUTICS INC VERA | COMMODORE CAPITAL LP | 5,001,783 11.3% | 2,658,926 (+113.49%) | View |
| 2024-02-14 3:21 pm Unchanged | 13G | VERA THERAPEUTICS INC VERA | Ares Trading S.A. | 1,913,501 3.6% | 0 (Unchanged) | View |
| 2024-02-14 12:49 pm Purchase | 13G | VERA THERAPEUTICS INC VERA | Kynam Capital Management LP | 3,650,339 8.22% | 2,241,241 (+159.06%) | View |
| 2024-02-12 4:38 pm Purchase | 13G | VERA THERAPEUTICS INC VERA | Woodline Partners LP | 1,140,632 2.2% | 1,140,632 (New Position) | View |
| 2024-02-09 10:05 am Sale | 13G | VERA THERAPEUTICS INC VERA | FMR LLC | 2,774,372 6.243% | -533,238 (-16.12%) | View |
| 2024-02-05 4:45 pm Purchase | 13D | VERA THERAPEUTICS INC VERA | Longitude Capital Partners IV LLC | 5,164,062 9.8% | 9,925 (+0.19%) | View |
| 2024-01-29 5:25 pm Purchase | 13G | VERA THERAPEUTICS INC VERA | BlackRock Inc. BLK | 2,754,894 6.2% | 2,754,894 (New Position) | View |
| 2023-11-13 09:02 am Sale | 13G | VERA THERAPEUTICS INC VERA | FMR LLC | 3,307,610 7.463% | -841,036 (-20.27%) | View |
| 2023-08-02 5:01 pm Sale | 13D | VERA THERAPEUTICS INC VERA | Carlyle Group Inc. CG | 1,872,764 4.2% | -544,073 (-22.51%) | View |
| 2023-07-05 4:17 pm Sale | 13D | VERA THERAPEUTICS INC VERA | Carlyle Group Inc. CG | 2,416,837 5.5% | -543,394 (-18.36%) | View |
| 2023-04-13 4:06 pm Sale | 13D | VERA THERAPEUTICS INC VERA | Carlyle Group Inc. CG | 2,960,231 6.7% | -9,925 (-0.33%) | View |
| 2023-02-16 4:40 pm Purchase | 13D | VERA THERAPEUTICS INC VERA | Longitude Capital Partners IV LLC | 5,154,137 12.3% | 1,714,285 (+49.84%) | View |
| 2023-02-16 4:05 pm Purchase | 13G | VERA THERAPEUTICS INC VERA | COMMODORE CAPITAL LP | 2,342,857 5.6% | 2,342,857 (New Position) | View |
| 2023-02-14 4:45 pm Sale | 13G | VERA THERAPEUTICS INC VERA | RA CAPITAL MANAGEMENT L.P. | 0 0% | -2,000,000 (Position Closed) | View |
| 2023-02-14 08:02 am Sale | 13G | VERA THERAPEUTICS INC VERA | CITADEL ADVISORS LLC | 1,991,553 7.2% | -50,867 (-2.49%) | View |
| 2023-02-13 8:43 pm Purchase | 13D | VERA THERAPEUTICS INC VERA | Sofinnova Venture Partners X L.P. | 3,477,081 8.3% | 285,714 (+8.95%) | View |